Logo

American Heart Association

  10
  0


Final ID: WP141

Cardiac Troponin is Infrequently Tested in Emergency Department Patients with Suspected Stroke

Abstract Body: Background:
A recent prospective study reported that myocardial infarction (MI) was present in nearly half of ischemic stroke patients with substantially elevated troponin, with 1 in 5 having a type 1 MI. The proportion of stroke patients in whom cardiac troponin, a key component of diagnosing MI, is checked at Emergency Department (ED) presentation is unknown. We therefore used population-level data to report the frequency of cardiac troponin assessments among U.S. patients presenting emergently with stroke symptoms and to identify factors associated with cardiac troponin testing.

Methods:
Using the National Hospital Ambulatory Medical Care Survey (NHAMCS), which provides data from a nationally representative sample of EDs in the U.S., we analyzed patients presenting from 2016 to 2021 with an initial diagnosis of stroke, defined by ICD-10 codes in any diagnostic position as abstracted from free text responses by ED staff. The study exposure was cardiac troponin testing, which is a collected variable in NHAMCS. We applied survey weights to calculate national estimates and 95% confidence intervals (CI). Survey-weighted tests of comparison were used to compare demographics and clinical features between visits in which troponin was tested versus not. We constructed a multivariable conditional logistic regression model to evaluate potential associations between demographic and clinical factors and troponin testing in the ED.

Results:
An estimated 5.8 ([95% CI, 4.8-5.7) million patients or 0.69% (95% CI, 0.58-0.80%) of all ED visits during the study period were for suspected stroke. Mean age was 67.8 (95% CI, 66.5-69.2) years and 53.1% (95% CI, 48.2-57.9) were women. In suspected stroke patients, 26.1% (95% CI, 20.9-32.2%) had troponin tested in the ED. In unadjusted analysis, factors significantly associated with troponin testing were a triage complaint of chest pain, older age, higher mean systolic BP, hypertension, diabetes, obesity, stroke or TIA, congestive heart failure, or coronary disease. In a multivariable model, only elevated systolic blood pressure was significantly associated with having cardiac troponin tested in the ED (p= 0.02).

Conclusion:
Using population-level data, we found that only 1 in 4 patients with a suspected stroke had troponin tested in the ED. There appears to be an opportunity to improve MI detection among stroke patients in the U.S.
  • Kolludra, Kleona  ( NewYork-Presbyterian Hospital , New York , New York , United States )
  • Navi, Babak  ( Weill Cornell Medicine , New York , New York , United States )
  • Merkler, Alexander  ( Weill Cornell Medicine , New York , New York , United States )
  • Kamel, Hooman  ( Weill Cornell Medicine , New York , New York , United States )
  • Liberman, Ava  ( Weill Cornell Medicine , New York , New York , United States )
  • Author Disclosures:
    Kleona Kolludra: DO NOT have relevant financial relationships | Babak Navi: DO have relevant financial relationships ; Independent Contractor:MindRhythm, Inc.:Past (completed) | Alexander Merkler: No Answer | Hooman Kamel: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Financial disclosures for Hooman Kamel: a PI role in the ARCADIA trial, which received in-kind study drug from the BMS-Pfizer Alliance for Eliquis and ancillary study support from Roche Diagnostics; a Deputy Editor role for JAMA Neurology; clinical trial steering/executive committee roles for the STROKE-AF (Medtronic), LIBREXIA-AF (Janssen), and LAAOS-4 (Boston Scientific) trials; consulting or endpoint adjudication committee roles for AbbVie, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk; and household ownership interests in TETMedical, Spectrum Plastics Group, and Ascential Technologies.:Active (exists now) | Ava Liberman: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Health Services, Quality Improvement, and Patient-Centered Outcomes Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
More abstracts from these authors:
Use of Aspirin-Ticagrelor after Moderate Ischemic Stroke in Get With The Guidelines-Stroke

Liberman Ava, Zhang Cenai, Kamel Hooman, Navi Babak, Rostanski Sara, White Halina, Xian Ying

Posterior Circulation Stroke is Associated with Increased Risk of Misdiagnosis as Compared to Anterior Circulation Stroke in a Multistate Cohort

Farnes Kara, Zhang Cenai, Navi Babak, Razzak Junaid, Kamel Hooman, Liberman Ava

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)